The Future of Cardiovascular Biologics: Projected Growth to USD 4.23 Billion by 2033 The cardiovascular biologics market, driven by RNA therapies, is anticipated to reach USD 4.23 billion by 2033, highlighting a 7.5% CAGR fueled by innovative treatments addressing cardiovascular diseases.

The Future of Cardiovascular Biologics: Projected Growth to USD 4.23 Billion by 2033 #United_States #Austin #RNA_Therapies #Monoclonal_Antibodies #Cardiovascular_Biologics